- Report
- December 2024
- 125 Pages
Global
From €4464EUR$4,650USD£3,725GBP
- Report
- October 2024
- 183 Pages
Global
From €3403EUR$3,545USD£2,840GBP
€3781EUR$3,939USD£3,155GBP
- Report
- March 2025
- 200 Pages
Global
From €2390EUR$2,490USD£1,995GBP
- Report
- March 2025
- 93 Pages
Global
From €5376EUR$5,600USD£4,486GBP
- Report
- February 2025
- 200 Pages
Global
From €4310EUR$4,490USD£3,597GBP
- Report
- February 2025
- 150 Pages
Global
From €2879EUR$2,999USD£2,402GBP
- Clinical Trials
- November 2024
- 240 Pages
Global
From €2880EUR$3,000USD£2,403GBP
- Report
- September 2024
- 314 Pages
Global
From €7632EUR$7,950USD£6,368GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2880EUR$3,000USD£2,403GBP
- Report
- April 2024
- 180 Pages
Global
From €4320EUR$4,500USD£3,605GBP
- Report
- December 2022
- 196 Pages
Global
From €4899EUR$5,282USD£3,950GBP
- Report
- June 2023
- 103 Pages
Global
From €5712EUR$5,950USD£4,766GBP
- Report
- February 2023
- 244 Pages
Global
From €4032EUR$4,200USD£3,364GBP
- Report
- August 2022
- 119 Pages
Global
From €4320EUR$4,500USD£3,605GBP
- Report
- January 2024
- 200 Pages
Japan
From €5520EUR$5,750USD£4,606GBP
- Report
- February 2024
- 117 Pages
Global
From €4560EUR$4,750USD£3,805GBP
- Report
- April 2023
- 147 Pages
Global
From €4751EUR$4,949USD£3,964GBP
- Report
- December 2022
- 112 Pages
Global
From €4320EUR$4,500USD£3,605GBP
- Report
- May 2020
- 218 Pages
Global
From €14395EUR$14,995USD£12,012GBP
- Drug Pipelines
- February 2019
- 300 Pages
Global
From €21120EUR$22,000USD£17,623GBP

Galantamine is a drug used to treat mild to moderate Alzheimer's Disease. It is an acetylcholinesterase inhibitor, meaning it works by increasing the amount of the neurotransmitter acetylcholine in the brain. This helps to improve memory, thinking, and behavior in people with Alzheimer's. Galantamine is available in both oral and intravenous forms, and is often used in combination with other Alzheimer's medications. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea.
Galantamine is one of several drugs used to treat Alzheimer's Disease, and is often prescribed alongside other medications such as donepezil and memantine. It is available in generic form, as well as under the brand names Razadyne and Reminyl.
Companies in the Galantamine market include Janssen Pharmaceuticals, Eisai Co., Ltd., and Shire Pharmaceuticals. Show Less Read more